Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant-Reference-Cited by-同舟云学术

Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant

Published:2015-02-24 Issue:3 Volume:20 Page:168-176
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Rivelli Regiane F¹²,Gonçalves Renato T¹²,Leite Maurilo¹²,Santos Marcos André R¹²,Delgado Alvimar G¹²,Cardoso Lucio R¹²,Takiya Christina M²³

Affiliation:

1. Faculty of Medicine; Federal University of Rio de Janeiro; CEP 21941-902 Rio de Janeiro Brazil

2. Nephrology Service; University Hospital Clementino Fraga Filho; Federal University of Rio de Janeiro; CEP 21941-902 Rio de Janeiro Brazil

3. Institute of Biophysics Carlos Chagas Filho; Federal University of Rio de Janeiro; CEP 21941-902 Rio de Janeiro Brazil

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12368/fullpdf

Reference35 articles.

1. The natural history of chronic allograft nephropathy;Nankivell;N. Engl. J. Med.,2003

2. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity;Goldfarb;J. Urol.,2003

3. Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506;Akool el;J. Immunol.,2008

4. Oligomeric structure of type I and type II transforming growth factor beta receptors: Homodimers form in the ER and persist at the plasma membrane;Gilboa;J. Cell Biol.,1998

5. How cells read TGF-beta signals;Massague;Nat. Rev. Mol. Cell Biol.,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosis;American Journal of Physiology-Renal Physiology;2023-05-01

2. Pharmacological Treatment of Fibrosis: a Systematic Review of Clinical Trials;SN Comprehensive Clinical Medicine;2020-05

3. Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation;Journal of Clinical Medicine;2020-01-23

4. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients;Cochrane Database of Systematic Reviews;2019-12-16

5. Preventive effect of early introduction of everolimus and reduced-exposure tacrolimus on renal interstitial fibrosis in de novo living-donor renal transplant recipients;Clinical and Experimental Nephrology;2019-12-02